Ginkgo Bioworks Holdings, Inc.
DNA
$6.79
-$0.45-6.22%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 43.44% | -2.27% | 0.00% | -33.92% | 33.70% |
| Total Depreciation and Amortization | 92.06% | -4.06% | 5,235.12% | -99.14% | 83.10% |
| Total Amortization of Deferred Charges | -200.00% | -10.64% | -66.43% | 433.33% | -200.00% |
| Total Other Non-Cash Items | -91.23% | -13.30% | 102.78% | -26.71% | -8.06% |
| Change in Net Operating Assets | 7.28% | 39.89% | -271.21% | 157.09% | -252.26% |
| Cash from Operations | 5.17% | 2.08% | -50.85% | 21.48% | 21.87% |
| Capital Expenditure | -35.49% | -38,560.00% | -- | 100.00% | 99.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -45.32% | -73.48% | 229.82% | -14.04% | 66.58% |
| Cash from Investing | -52.07% | -75.68% | 230.60% | -13.97% | 67.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 24.00% | -4.17% | 75.51% | 52.66% |
| Issuance of Common Stock | -- | -- | -11.29% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -177.46% | -- | -- |
| Cash from Financing | 86,884.21% | -100.23% | -18.07% | 10,240.82% | 52.66% |
| Foreign Exchange rate Adjustments | 133.33% | 15.13% | -263.44% | -50.00% | 151.35% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 29.74% | -142.77% | 158.70% | 9.29% | 58.43% |